At the time of writing, Lifecore Biomedical Inc [LFCR] stock is trading at $8.19, down -0.49%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The LFCR shares have gain 18.01% over the last week, with a monthly amount glided 18.70%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Craig Hallum started tracking the stock with Buy rating on September 05, 2024, and set its price target to $8. On August 28, 2024, downgrade downgraded it’s rating to Mkt Perform. Stephens downgraded its rating to a Equal-Weight and decreased its price target to $2 on March 20, 2023.
For the past year, the stock price of Lifecore Biomedical Inc fluctuated between $3.68 and $8.63. Currently, Wall Street analysts expect the stock to reach $6.5 within the next 12 months. Lifecore Biomedical Inc [NASDAQ: LFCR] shares were valued at $8.19 at the most recent close of the market. An investor can expect a potential drop of -20.63% based on the average LFCR price forecast.
Analyzing the LFCR fundamentals
According to Lifecore Biomedical Inc [NASDAQ:LFCR], the company’s sales were 130.31M for trailing twelve months, which represents an -1.54% plunge. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.34%, and Net Profit Margin reading is -0.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -2.64 and Total Capital is -0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 58.48.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.01 points at the first support level, and at 7.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.36, and for the 2nd resistance point, it is at 8.54.
Ratios To Look Out For
It is important to note that Lifecore Biomedical Inc [NASDAQ:LFCR] has a current ratio of 2.71. As well, the Quick Ratio is 1.59, while the Cash Ratio is 0.17. Considering the valuation of this stock, the price to sales ratio is 2.33, the price to book ratio is 136.05.
Transactions by insiders
Recent insider trading involved English Aron R., 10% Owner, that happened on May 27 ’25 when 1.14 million shares were sold. 10% Owner, English Aron R. completed a deal on May 28 ’25 to sell 0.15 million shares. Meanwhile, 10% Owner English Aron R. sold 96137.0 shares on May 23 ’25.
